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Abstract (248 words) 1 
Background: Identifying variations by age in the prevalence of depression would be 2 
instrumental in supporting case detection and targeted prevention. Our aim was to determine 3 
these variations in the UK. Methods: A representative sample of the UK population (n=17,152) 4 
from the European Health Interview Survey of 2014 was included in the analyses. The Patient 5 
Health Questionnaire (PHQ-8) was used to assess the prevalence of depressive symptoms and 6 
of probable depressive disorder. Prevalence estimates (95%CI) were calculated. The 7 
association between prevalence and age was assessed using multivariable multinomial logistic 8 
and logistic regression models. All analyses were carried out for the total sample and stratified 9 
by sex. Results: The prevalence of depressive symptoms ranged from 11.3% (10.6-11.9) for 10 
mild, to 3.3% (3.0-3.7) for severe symptoms. The prevalence of probable depressive disorder 11 
was 7.5% (95%CI: 7.0-8.0). A significantly higher prevalence of probable depressive disorder 12 
was found in those aged 45 to 59 years old compared with those aged 16 to 29.  For the 13 
prevalence of severe depressive symptoms those age differences were even higher: 2.55 times 14 
higher (5.38 for men and 1.75 for women). Limitations: The cross-sectional design precludes 15 
stablishing the direction of the relationship between age and the prevalence. Conclusions: The 16 
prevalence and age patterns of depression in the UK were described. A peak in the prevalence 17 
was identified during middle adulthood. These results could serve as a reference for the 18 
monitoring of depression in the UK and the development of preventive strategies, particularly 19 
in the high-risk population groups identified.  20 
 21 
 22 






Depressive disorders are prevalent and place a significant burden on patients and health 27 
systems (James et al., 2018; World Health Organization, 2017). These disorders are one of the 28 
foremost causes of disability, are associated with reductions in quality of life for patients and 29 
their families, and generate a substantial expenditure of resources for health systems (James et 30 
al., 2018; Kyu et al., 2018; Moussavi et al., 2007). Variations by country and over time in the 31 
prevalence of depression have been systematically reported (Auerbach et al., 2016; 32 
Bretschneider et al., 2018; Bromet et al., 2011; James et al., 2018; World Health Organisation 33 
(WHO), 2011). A periodic evaluation for each country could be highly valuable for monitoring 34 
the prevalence of depression, planning health resources and to improve preventive measures 35 
through identifying higher risk groups. 36 
In the United Kingdom (UK), the Adult Psychiatric Morbidity Survey (APMS) has provided 37 
information on Mental Health and Wellbeing in the population aged 16 and over since 1993 38 
(NHS Digital, 2014). Whilst the emphasis of APMS is on common mental disorders, including 39 
both depression and anxiety, it also reports the prevalence of depressive episode assessed using 40 
the Clinical Interview Schedule-Revised (CIS-R) (Lewis et al., 1992). This prevalence was 41 
estimated by the APMS in 2014 to be between 2% and 6%. However, since 2007 the APMS 42 
collects information only for England and not for Scotland, Wales and Northern Ireland. In 43 
addition to the APMS, other studies within the UK have tried to determine the prevalence of 44 
depression such as the Outcome of Depression International Network study (ODIN) or the 45 
South East London Community Health Study (SELCoH) (Ayuso-Mateos et al., 2001; Hatch et 46 
al., 2012). These studies, based in selected samples from Liverpool in the case of the ODIN 47 
study (Ayuso-Mateos et al., 2001), and south east London in the case of the SELCoH study 48 
(Hatch et al., 2012), have reported higher prevalence estimates for depression, varying between 49 
5% and 15% depending on the specific study. Besides the differences in the population 50 
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considered, variations in the figures reported could be caused by different factors, such as 51 
differences in the study period and in the measure of depression severity (Chang et al., 2008). 52 
Hence, to obtain a clear representation of the prevalence and severity of depressive symptoms 53 
in the UK, it would be appropriate to make an assessment using a population representative 54 
sample of the whole country.  55 
Both sex and age have been systematically related to the prevalence of depression (Arias-de la 56 
Torre et al., 2018; Kessler et al., 2010; Patel et al., 2018a). While a higher prevalence of 57 
depressive symptoms has consistently been found in women compared to men, the relationship 58 
of the prevalence with age is less clear. The most recent APMS suggested a peak of prevalence 59 
among the middle-aged population, independent of their sex, and a possible increased 60 
prevalence of depressive symptoms in young women (NHS Digital, 2014). It should also be 61 
highlighted that the relationship between age and the prevalence of depressive symptoms might 62 
vary depending on depression severity (Salk et al., 2017). While the younger population might 63 
have higher rates of mild depression, the prevalence of severe depression could be higher 64 
among the older population (Patel et al., 2018b).  65 
Taking this into consideration, the aims of the current study were: a) to determine the 66 
prevalence of depressive symptoms and of probable depressive disorder in the UK, and b) to 67 
examine its association with age and sex. 68 
Methods 69 
A cross-sectional study using data from the UK edition of the second wave of the European 70 
Health Interview Survey (EHIS) was carried out. EHIS is a nationwide representative survey 71 
conducted in all EU member states, Iceland, Norway and Turkey, which began in 2006 72 
(Eurostat, 2018). A survey was conducted for the second wave between 2013 and 2015 73 
including health related and socioeconomic variables (Eurostat, 2015). The EHIS sample for 74 
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the UK was selected using a simple random sampling method based on the household as the 75 
sampling unit. This sampling method, in essence, consists of random selection from the target 76 
population of the number of households required to reach a previously determined effective 77 
sample size, after assigning weights to the selected households according to their 78 
characteristics. Approximately 25% of the sample was interviewed face-to-face and 75% by 79 
telephone, with a response rate about 60%. The non-response rate was compensated in EHIS 80 
using an approach based on sample sizes and weighting. The minimum effective sample size 81 
is the size required if the survey was based on simple random sampling. The actual sample size 82 
is the number of sample units interviewed. The actual sample size should be larger to the extent 83 
that the design effects exceed 1.0 and to compensate for all kinds of non-response (Eurostat, 84 
2018). In the UK, the ratio between the actual effective sample size and the estimated minimum 85 
effective sample size was 1.08 and thus it could be assumed that the effects of the non-response 86 
rate were compensated. In addition, EHIS sampling weights were designed to compensate 87 
unequal probabilities of selection and non-response adjustments (Eurostat, 2018). For this 88 
study, we included 17,706 non-institutionalized individuals that completed the 8-item Patient 89 
Health Questionnaire (PHQ-8), a valid and reliable tool used to assess depressive symptoms 90 
based on DSM-IV criteria(Wu et al., 2019). Individuals with missing values in any of the 91 
independent variables were excluded (n=554; 3.1%). 92 
Study measures 93 
The presence of depressive symptoms and of probable depressive disorder assessed with the 94 
PHQ-8 were the main outcomes of the study. PHQ-8 questionnaire is composed of 8 Likert 95 
type items with responses ranging from 0 (Not at all) to 3 (Nearly every day). The final score 96 
is computed by adding the score for each of the items ranging from 0 to 24. In accordance with 97 
the developmental study of the PHQ-8 (Kroenke et al., 2009), to assess depressive symptoms, 98 
a categorical variable with the following levels was considered: mild (PHQ-8: 5-9), moderate 99 
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(PHQ-8: 10-14) and severe depressive symptoms (PHQ-8≥15). Additionally, to assess 100 
probable depressive disorder, a score equal to or higher than 10 (PHQ-8≥10) was considered 101 
as positive. According to previous validation studies (Levis et al., 2019; Wu et al., 2019), this 102 
cut-off value has a sensitivity >75% and a specificity >85% to detect depressive disorders 103 
including major depressive disorder and dysthymia. 104 
The main explanatory factor of this study was age (categorical: 16 to 29, 30 to 44, 45 to 59, 60 105 
to 74 and 75 or more years old). Furthermore, based on evidence from previous research (Arias-106 
de la Torre et al., 2018; De Wit et al., 2009; Maske et al., 2016; Onyike et al., 2003; Rai et al., 107 
2013), sex and the following confounders were considered as covariates for the adjustment of 108 
models: interview method, birthplace, degree of urbanization of the individuals’ residence area, 109 
Body Mass Index (BMI) derived from self-reported height and weight of participants 110 
(categorized), and social support evaluated with the Oslo Social Support (OSS) scale and 111 
considered as a categorical variable (Kocalevent et al., 2018). 112 
Statistical analysis 113 
A descriptive analysis of the characteristics of the study sample was carried out. The prevalence 114 
of depressive symptoms, of probable depressive disorder and their 95% Confidence Intervals 115 
(95%CI) according to age and sex were calculated. To assess the relationship of the prevalence 116 
with age, bivariable and multivariable multinomial (polytomous) logistic regression models for 117 
depressive symptoms and binary logistic regression models for probable depressive disorder 118 
(PHQ-8≥10) were performed. From these models, crude and adjusted Relative Odds Ratios 119 
(ROR and aROR respectively) and crude and adjusted Odds Ratios (OR and aOR respectively) 120 
together with their 95%CI were obtained (Szklo and Nieto, 2014). To assess the statistical 121 
significance of age within the models, Wald tests were used. Multivariable regression models 122 
were adjusted by all the covariates selected. The absence of multicollinearity and of interaction 123 
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between all the covariates and age were tested. To ensure representativeness and to obtain 124 
variance estimates that account for the sampling design, sampling weights using Taylor series 125 
linearization were applied for the analyses(West and Mccabe, 2012). The level of significance 126 
was set at 0.01. All analyses were performed using the statistical software Stata v.16 (“Stata 127 
Statistical Software: Release 16,” 2019). 128 
Results 129 
Analyses were carried out in a sample of 17,152 individuals, of whom. 53.8% were women, 130 
88.1% were born in the UK (88.1% of men and 88.2% of women), 54.4% resided in densely 131 
populated areas (53.4% of men and 55.2% of women), 45.1% had a BMI between 18.5 and 132 
24.9 (40.9% of men and 48.7% of women) and had moderate-strong social support according 133 
to the OSS score (Table1).  134 
The prevalence of both depressive symptoms and of a probable depressive disorder was higher 135 
among women than among men. Table 2 shows the distribution of the prevalence of depressive 136 
symptoms and probable depressive disorder by age and sex. The prevalence of depressive 137 
symptoms ranged from 11.3% (95%CI 10.6-11.9) for mild depressive symptoms, 4.2% 138 
(95%CI: 3.8-4.6) for moderate depressive symptoms and 3.3% (95%CI: 3.0-3.7) for severe 139 
depressive symptoms (Supplementary file 1). The prevalence of a probable depressive disorder 140 
was 7.5% (95%CI: 7.0-8.0). A higher prevalence of probable depressive disorder was observed 141 
for those aged 45 to 59 for both sex (Figure 1). Among men, lower prevalence was found in 142 
the younger population (16 to 29 years old) both in all levels of depressive symptoms and in 143 
probable depressive disorder. Among women, a higher prevalence was found in younger (16 144 
to 29), middle-aged (45 to 59) and older (75 or more) population groups both in all levels of 145 
depressive symptoms except for mild, and in probable depressive disorder. 146 
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Significant differences related to age were only found in severe depressive symptoms (Table 147 
3). A higher prevalence of severe symptoms was found among those between 45 to 59 years 148 
old compared with those aged 16 to 29 years (aROR: 2.55 95%CI: 1.60-4.06). For men, 149 
statistically significant differences in the prevalence of mild and severe depressive symptoms 150 
related to age were found. The prevalence of mild depressive symptoms (aROR: 1.76, 95%CI: 151 
1.15-2.71) and severe depressive symptoms (aROR: 5.38, 95%CI: 2.51-11.53) was higher in 152 
middle-age men (45-59 years) than in younger men (16-29 years). Among women, 153 
significantly higher prevalence of severe symptoms (ROR: 1.78, 95%CI: 1.04-3.06) was found 154 
at the bivariable level in the middle-aged (45-59 years) group compared with younger (16-29 155 
years) women. In multivariable analysis, the prevalence of severe depressive symptoms was 156 
higher in middle-aged women compared to younger women (aROR: 1.75, 95%CI: 0.99-3.10), 157 
but this difference was not statistically significant.  158 
The prevalence of probable depressive disorder (PHQ-8≥10) was also related with age (Table 159 
4). The group aged between 45 and 59 years had a significantly higher prevalence than the 160 
younger population in the total sample (aOR: 1.82, 95%CI: 1.32-2.50) and in men (aOR: 2.84, 161 
95%CI: 1.57-5.14). Among women, while statistically significant differences were found for 162 
the group aged between 45 and 59 at bivariable level (OR: 1.48, 95%CI: 1.03-2.12), no 163 
significant differences at multivariable level were found.  164 
Discussion  165 
Based on a representative sample, our study showed that the prevalence of depressive 166 
symptoms in the UK ranged from 11.3% with mild symptoms to 3.3% with severe depressive 167 
symptoms. Furthermore, the prevalence of probable depressive disorder in the UK was 7.5% 168 
(6.2% and 8.6% for men and women respectively). All these estimates varied largely according 169 
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to age with a peak of prevalence, particularly of severe depressive symptoms, in the population 170 
aged between 45 to 59 years old. 171 
The prevalence estimates of probable depressive disorder reported in the present study are 172 
slightly higher than those reported by the APMS in 2014 using a different measure (CIS-R) 173 
(NHS Digital, 2014), but are similar to those observed in the same year in other high-income 174 
countries using the PHQ-8 such as Germany (around 7.4%) and Spain (approximately 6.5%) 175 
(Arias-de la Torre et al., 2018; Bretschneider et al., 2018). Regarding the higher prevalence we 176 
found compared to the APMS, it is important to note that the measures used to ascertain 177 
depression (PHQ-8 in the former and CIS-R in the latter) are different. It should be mentioned 178 
the possible differences related to the timeframe of the tools used for the evaluation of 179 
depression (two weeks for the PHQ-8 used in EHIS and one week for the CIS-R used in the 180 
APMS). The use of a screening tool to determine probable depressive disorder, as is the PHQ-181 
8, could lead to classify as cases some individuals that, while at risk of having a depressive 182 
disorder, might not be classified as such using a structured interview as CIS-R. In addition, the 183 
study populations also varied between EHIS and the APMS: EHIS examined a representative 184 
sample from the whole UK, whereas the APMS focused on England only. Despite these 185 
differences, variation in the prevalence patterns by age were similar in both surveys, with a 186 
clear peak between age 45 and 59 for both sex (NHS Digital, 2014). Accordingly, our results 187 
corroborate that individuals between 45 and 59 years are the age group with the highest risk of 188 
depression in the UK. 189 
It should be noted that a higher crude prevalence was found in women than men in all age 190 
groups and a significantly higher prevalence was found in most of the cases only for the group 191 
between 45 to 59 years old. Among men aged 45 to 59 years, the prevalence of probable 192 
depressive disorder was almost triple that found in the youngest group, and this increased to 193 
more than 5.3 times higher for severe symptoms. In women, the prevalence of severe 194 
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depressive symptoms was more than 1.7 times higher than in younger women. It should be 195 
highlighted that while among men the relationship of age with the prevalence of depressive 196 
symptoms becomes more relevant as severity increases, among women the strength of these 197 
relationships is lower. These results suggest that the role of age as a determinant of depression 198 
might vary according to both sex and the severity level considered. Moreover, these findings 199 
might be explained by a number of reasons, such as period factors (e.g. the possible higher 200 
impact on group aged 45 to 59 of the previous economic recession period, particularly in those 201 
belonging to the most disadvantaged groups) and other potential mediators in the relationship 202 
of age and depression (e.g. inflammation increasing with age or family and social roles) (Arias-203 
de la Torre et al., 2019b, 2019a; Dijkstra-Kersten et al., 2015; Dregan et al., 2020; Hong et al., 204 
2011; Niedzwiedz et al., 2017; Perry et al., 2020). Further longitudinal research to elucidate 205 
the causes of the increased rates of depression in this age group in the UK could be valuable to 206 
better understand them. Furthermore, the results suggest that targeted screening and preventive 207 
strategies in this high-risk population group (middle-aged adults) may help reduce the 208 
prevalence of depression in the UK population, particularly in the case of severe depression. 209 
Evidence from other countries (Arias-de la Torre et al., 2018; Luppa et al., 2012; Maske et al., 210 
2016), suggests that the prevalence of depression tends to increase as the age increases. Such 211 
variability between countries in the age patterns, might be explained by methodological and 212 
health-related factors, such as differences in the populations analized and reporting bias 213 
between countries, differences in the access to health care resources and treatments in older 214 
population, and differences in welfare regimes and social protection policies. Due to the high 215 
differences between countries in these factors, the prevalence in the middle-age group might 216 
be higher in the UK than in southern or central European countries (Arias-de la Torre et al., 217 
2019b; Bambra, 2011; Bambra and Eikemo, 2008; Reibling, 2010). New research using 218 
homogeneous samples from countries with different healthcare systems and social protection 219 
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policies, could be valuable to understand differences between countries in the age patterns of 220 
depression.    221 
Another finding was the high prevalence of mild depressive symptoms found in those aged 75 222 
years or more (9.3% for men and 12.9% for women) and in younger women (14.4%). The mild 223 
depressive symptoms category is under the cut-off value (10+) consistently proposed to 224 
determine the presence of depression using the PHQ-8 and, therefore, could be indicative of 225 
subclinical depression or depressive mood (Levis et al., 2019; Moriarty et al., 2015; Salk et al., 226 
2017). In older ages, the presence of mild depressive symptoms are strongly associated with 227 
an increased risk of mortality, decline of overall health status and low quality of life (Cai et al., 228 
2020; Holwerda et al., 2016; Sivertsen et al., 2015). In younger women, while in many cases 229 
mild depressive symptoms could have a remission in the late 20s (Patton et al., 2014), some of 230 
them could develop more severe symptoms and a depressive disorder over adulthood. These 231 
results suggest that the mild symptomatic group in early adulthood might be a fruitful target 232 
for early intervention or targeted preventive strategies.  233 
Some limitations of the study should be discussed. First, the use of a screening tool to determine 234 
the presence of probable depressive disorder and the severity of depressive symptoms. 235 
However, the PHQ-8 shows suitable psychometric properties for its use as a screening tool 236 
when compared to clinical interviews, showing a very high (but not perfect) sensitivity and 237 
specificity to detect major depressive disorders at the general population level (Levis et al., 238 
2019; Moriarty et al., 2015; Wu et al., 2019). Another limitation is related to potential bias 239 
from how the information on depressive symptoms was gathered (approximately 25% of the 240 
sample was interviewed face-to-face and 75% by telephone). However, previous evidence 241 
suggests that the information gathering methods might not influence the results when assessing 242 
psychiatric disorders (Fenig et al., 1993; Rohde et al., 1997), and particularly when using the 243 
PHQ (Pinto-Meza et al., 2005). Additionally, despite the differences in the prevalence in the 244 
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sample used in our study (Supplementary file 2) and their potential influence in the 245 
relationships shown, as the interview method was adjusted for in multivariable, this potential 246 
source of bias could be considered, at least, partially controlled. Future research considering 247 
the potential effect of different administration methods could be valuable to obtain new 248 
evidence related to this aspect and improve the accuracy of mental health interview surveys.  It 249 
should be also mentioned that  people with mental disorders could be less likely to participate 250 
in cross-sectional population surveys and therefore our results may be under-estimates of true 251 
population prevalence (Arias-de la Torre et al., 2020; Knudsen et al., 2010). Despite this 252 
limitation, as our aim was to assess differences in prevalence according to age, the relationships 253 
and patterns found might be considered relevant although  under-estimation is possible.  It 254 
should be also noted the lack of inclusion of socioeconomic status and other sociodemographic 255 
variables (e.g. educational level and marital status) in multivariable models. These variables 256 
could interact with age having a mediational or indirect effect in the relationship between age 257 
and depression. Therefore, including these interactions within the multivariable models, could 258 
lead to misinterpretations of the differences in prevalence by age. Finally, we should point out 259 
that EHIS data has no information on other relevant variables, such as ethnicity or family 260 
history of depression. However, EHIS captures a wide range of variables consistently related 261 
to the prevalence of depressive symptoms (e.g. age, sex, demographic factors, BMI, and social 262 
support) (Eurostat, 2018). Therefore, the results of the current study could be considered as 263 
relevant in terms of their capability to be extrapolated to the UK population. 264 
In conclusion, our study shows the prevalence of depressive symptoms (from 11.3% with mild 265 
symptoms to 3.3% with severe symptoms) and of probable depressive disorder (7.5%) in the 266 
UK. Furthermore, a clear peak in the prevalence of depression, and particularly of severe 267 
depressive symptoms, was identified during middle adulthood (from 45 to 59 years). Given the 268 
representativeness of the sample (including England, Scotland, Wales, and Northern Ireland) 269 
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these results could serve as a reference for the monitoring of depression in the UK, the planning 270 
of health resources, and the development of preventive and screening strategies targeting the 271 
higher risk population groups identified.  272 
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Table 1. Distribution of the study covariates. European Health Interview Survey 2014/2015.  
 Total                                                                            
(n=17,652)    
Men                                                    
(n=7,515; 46.3% 95%CI: 45.3-47.3)    
Women                                                          
(n=9,637; 53.8% 95%CI: 52.8-54.7)    
 n % (95%CI) n % (95%CI) n % (95%CI) 
Age       
  16 to 29  1,205 18.2 (17.2-19.2) 489 17.8 (16.3-19.4) 716 18.5 (17.2-19.9) 
  30 to 44  3,140 25.3 (24.5-26.3) 1,282 25.7 (24.4-27.1) 1,858 25.1 (24.0-26.3) 
  45 to 59  4,560 26.3 (25.5-27.1) 1,956 26.8 (25.6-28.0) 2,604 25.9 (24.8-26.9) 
  60 to 74  5,774 20.2 (19.6-20.8) 2,663 20.7 (19.8-21.7) 3,111 19.7 (18.9-20.5) 
  75 or more  2,473 10.0-9.5-10.5) 1,225 9.0 (8.4-9.6) 1,348 10.9 (10.2-11.5) 
Interview method       
  Face-to-face 4,322 26.3 (25.4-27.2) 1,873 25.7 (24.4-27.0) 2,449 26.8 (25.7-28.0) 
  Telephone 12,830 73.7 (72.8-74.6) 5,642 74.3 (73.0-75.7) 7,118 73.2 (72.0-74.3) 
Birthplace       
  Native-born 15,674 88.1 (87.4-88.8) 6,866 88.1 (87.1-89.0) 8,808 88.2 (87.2-89.1) 
  EU Member State 529 4.2 (3.8-4.7) 221 4.3 (3.6-5.0) 308 4.1 (3.6-4.7) 
  Non-EU country 949 7.7 (7.1-8.3) 428 7.6 (6.8-8.6) 521 7.7 (7.0-8.6) 
Residence area       
  Densely-populated  10,061 54.4 (53.4-55.4) 4,382 53.4 (51.9-55.0) 5,677 55.2 (53.9-56.5) 
  Intermediate-populated 4,651 29.1 (28.2-30.0) 2,048 29.9 (28.5-31.3) 2,603 28.4 (27.3-29.6) 
  Thinly-populated 2,440 16.5 (15.8-17.3) 1,083 16.7 (15.5-17.9) 1,357 16.3 (15.4-17.4) 
Body Mass Index       
  Less than 18.5 296 2.2 (1.9-2.6) 81 1.5 (1.1-2.0) 215 2.8 (2.3-3.3) 
  18.5 to less than 25 7,184 45.1 (44.0-46.1) 2,822 40.9 (39.4-42.4) 4,362 48.7 (47.4-50.0) 
  25 to less than 30 6,197 33.7 (32.8-34.7) 3,120 38.7 (37.2-40.1) 3,077 29.5 (28.4-30.7) 
  30 or more 3,475 19.0 (18.3-19.8) 1,492 19.0 (17.9-20.1) 1,983 19.1 (18.1-20.1) 
Social Support       
  Strong 8,989 50.9 (49.9-51.9) 3,698 47.6 (46.1-49.1) 5,291 53.7 (52.4-55.0) 
  Moderate 6,612 40.0 (39.0-40.9) 3,046 42.4 (40.9-43.9) 3,566 37.9 (36.7-39.2) 
  Poor 1,551 9.2 (8.6-9.8) 771 10.1 (9.0-11.1) 780 8.4 (7.7-9.2) 
n: absolute frequency of individuals (without weighting); %: Percentage for total sample and prevalence for Depression and severity levels. 95%CI: 95% Confidence Interval. 





Table 2. Prevalence of depressive symptoms and of probable depressive disorder. European Health Interview Survey 2014/2015. Bivariable analysis. 
 Depressive symptoms Probable depressive disorder 
  Mild (PHQ-8: 5-9) Moderate (PHQ-8: 10-14) Severe (PHQ-8>=15) (PHQ-8>=10) 
  % (95%CI) % (95%CI) % (95%CI) % (95%CI) 
Total  (n=17,152) 11.3 (10.6-11.9) 4.2 (3.8-4.6) 3.3 (3.0-3.7) 7.5 (7.0-8.0) 
Age     
  16 to 29 (n=1,205) 11.3 (9.4-13.6) 3.7 (2.6-5.2) 2.4 (1.6-3.6) 6.2 (4.7-7.9) 
  30 to 44 (n=3,140) 10.8 (9.6-12.1) 3.7 (3.0-4.6) 2.9 (2.3-3.6) 6.6 (5.7-7.7) 
  45 to 59 (n=4,560) 12.0 (11.0-13.2) 5.1 (4.5-5.9) 5.3 (4.6-6.1) 10.4 (9.5-11.5) 
  60 to 74 (n=5,774) 10.3 (9.4-11.3) 3.8 (3.3-4.4) 2.5 (2.1-3.0) 6.3 (5.3-7.1) 
  75 or more (n=2,473) 12.2 (10.8-13.7) 4.2 (3.4-5.2) 2.4 (1.7-3.2) 6.6 (5.5-7.8) 
     
Men  (n=7, 515) 9.3 (8.5-10.2) 3.5 (3.0-4.1) 2.7 (2.3-3.2) 6.2 (5.6-6.9) 
Age     
  16 to 29 (n=489) 7.7 (5.4-10.8) 2.6 (1.4-5.0) 1.2 (0.6-2.4) 3.8 (2.3-6.2) 
  30 to 44 (n=1,282) 8.9 (7.2-10-8) 2.8 (1.9-4.1) 2.9 (2.1-4.1) 5.7 (4.4-7.4) 
  45 to 59 (n=1,956) 11.5 (9.9-13.3) 4.8 (3.8-6.0) 4.5 (3.6-5.7) 9.3 (7.9-10.9) 
  60 to 74 (n=2,663) 8.1 (7.0-9.4) 3.7 (2.9-4.6) 2.0 (1.5-2.7) 5.7 (4.7-6.8) 
  75 or more (n=1,125) 10.2 (8.3-12.05) 2.9 (2.0-4.2) 1.4 (0.8-2.7) 4.3 (3.1-5.9) 
     
Women  (n=9,637) 12.9 (12.0-13.8) 4.8 (4.2-5.3) 3.8 (3.3-4.4) 8.6 (7.9-9.3) 
Age     
  16 to 29 (n=716) 14.4 (11.6-17.8) 4.6 (3.1-6.9) 3.4 (2.1-5.5) 8.1 (5.9-10.8) 
  30 to 44 (n=1,858) 12.5 (10.8-14.3) 4.5 (3.5-5.8) 2.9 (2.1-3.9) 7.4 (6.1-8.9) 
  45 to 59 (n=2,604) 12.5 (11.1-14.0) 5.5 (4.6-6.6) 6.0 (5.0-7.1) 11.5 (10.1-12.9) 
  60 to 74 (n=3,111) 12.3 (11.0-13.8) 4.0 (3.3-4.8) 3.0 (2.4-3.7) 6.9 (6.0-8.0) 
  75 or more (n=1,348) 13.5 (11.6-15.8) 5.1 (3.9-6.7) 3.0 (2.1-4.3) 8.6 (7.9-9.3) 
n: absolute frequency of individuals (without weighting); %: Prevalence of depressive symptoms and probable depressive disorder. 95%CI: 95% Confidence Interval. 
All percentages and standard errors were calculated taking into account the weights derived from the complex sample design using the Taylor series linearization method. 
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Table 3. Relationship of depressive symptoms with age and sex. European Health Interview Survey 2014/2015. Bivariable and mutivariable analysis. 
  
Mild symptoms 
(PHQ-8: 5-9; 11.3% 95%CI: 10.6-11.9) 
Moderate  symptoms 
(PHQ-8: 10-14; 4.2% 95%CI: 3.8-4.6) 
Severe  symptoms 
(PHQ-8>=15; 3.3% 95%CI: 3.0-3.7) 
 
  ROR (95%CI) aROR (95%CI) ROR (95%CI) aROR (95%CI) ROR (95%CI) aROR (95%CI) p (RPR) p (aROR) 
Total  (n=17,152)         
Age       <0.001 <0.001 
  16 to 29 1.00 1.00 1.00 1.00 1.00 1.00   
  30 to 44 0.95 (0.74-1.22) 0.94 (0.73-1.21) 1.00 (0.66-1.52) 1.02 (0.67-1.59) 1.19 (0.73-1.92) 1.35 (0.82-2.22)   
  45 to 59 1.12 (0.89-1.43) 1.06 (0.83-1.35) 1.47 (0.99-2.16) 1.41 (0.93-2.14) 2.32 (1.48-3.63) 2.55 (1.60-4.06)   
  60 to 74 0.90 (0.71-1.12) 0.87 (0.68-1.11) 1.01 (0.69-1.50) 1.02 (0.67-1.56) 1.02 (0.65-1.62) 1.21 (0.75-1.95)   
  75 or more 1.09-0.85-1.40) 1.01 (0.78-1.31) 1.14 (0.75-1.75) 1.10 (0.71-1.68) 0.99 (0.58-1.68) 0.91 (0.53-1.58)   
Men  (n=7,515)         
Age       <0.001 <0.001 
  16 to 29 1.00 1.00 1.00 1.00 1.00 1.00   
  30 to 44 1.19 (0.77-1.86) 1.28 (0.82-2.00) 1.12 (0.51-2.43) 1.18 (0.52-2.67) 2.46 (1.14-5.35) 3.07 (1.37-6.83)   
  45 to 59 1.68 (1.11-2.53) 1.76 (1.15-2.71) 2.03 (0.99-4.14) 2.07 (0.94-4.55) 4.13 (1.99-8.59) 5.38 (2.51-11.53)   
  60 to 74 1.08 (0.72-1.63) 1.16 (0.76-1.79) 1.43 (0.71-2.92) 1.50 (0.68-3.29) 1.69 (0.80-3.59) 2.31 (1.06-5.01)   
  75 or more 1.38 (0.89-2.15) 1.32 (0.83-2.10) 1.12 (0.52-2.46) 1.11 (0.51-2.43) 1.20 (0.47-3.09) 1.27 (0.48-3.38)   
Women  (n=9, 637)         
Age       <0.001 <0.001 
  16 to 29 1.00 1.00 1.00 1.00 1.00 1.00   
  30 to 44 0.84 (0.62-1.13) 0.79 (0.59-1.08) 0.94 (0.5-1.54) 0.95 (0.57-1.57) 0.81 (0.44-1.47) 0.86 (0.46-1.60)   
  45 to 59 0.89 (0.66-1.18) 0.77 (0.57-1.04) 1.21 (0.76-1.91) 1.10 (0.67-1.79) 1.78 (1.04-3.06) 1.75 (0.99-3.10)   
  60 to 74 0.82 (0.61-1.09) 0.73 (0.54-1.00) 0.82 (0.51-1.31) 0.80 (0.48-1.31) 0.83 (0.48-1.46) 0.88 (0.49-1.58)   
  75 or more 0.93 (0.69-1.27) 0.89 (0.65-1.22) 1.10 (0.66-1.82) 1.07 (0.65-1.76) 0.88 (0.47-1.65) 0.76 (0.39-1.45)   
n: absolute frequency of individuals (without weighting); %: prevalence of severity of depressive symptoms; 95%CI: 95% Confidence Interval; ROR: Relative Odds Ratio; aROR: Relative Odds Ratio adjusted 
for interview method, birthplace, degree of urbanization of the individuals’ residence area, Body Mass Index and social support (OSS). In the total sample aROR multivariable models were also adjusted by sex; p (RPR): and 
p (aROR): p value for age from Wald tests for bivariable and multivariable models respectively. 




Table 4. Relationship of probable depressive disorder with age and sex. European Health Interview Survey 
2014/2015. Bivariable and multivariable analysis. 
  
Pobable depressive disorder 
 (PHQ-8≥10: 7.5%; 95% CI: 7.0-8.0) 
  OR (95%CI) p aOR (95%CI) p 
Total sample (n=17,152)     
Age  <0.001  <0.001 
  16 to 29 1.00  1.00  
  30 to 44 1.08 (0.78-1.49)  1.17 (0.84-1.63)  
  45 to 59 1.78 (1.32-2.49)  1.82 (1.32-2.50)  
  60 to 74 1.03 (0.76-1.39)  1.12 (0.81-1.55)  
  75 or more 1.07 (0.77-1.50)  1.02 (0.73-1.44)  
Men  (n=7, 515)     
Age  <0.001  <0.001 
  16 to 29 1.00  1.00  
  30 to 44 1.52 (0.55-2.71)  1.70 (0.93-3.12)  
  45 to 59 2.56 (1.49-4.40)  2.84 (1.57-5.14)  
  60 to 74 1.51 (0.87-2.59)  1.74 (0.96-3.16)  
  75 or more 1.12 (0.61-2.07)  1.12 (0.60-2.12)  
Women  (n=9, 637)     
Age  <0.001  <0.001 
  16 to 29 1.00  1.00  
  30 to 44 0.91 (0.62-1.34)  0.95 (0.63-1.42)  
  45 to 59 1.48 (1.03-2.12)  1.43 (0.97-2.09)  
  60 to 74 0.55 (0.59-1.22)  0.88 (0.59-1.30)  
  75 or more 1.02 (0.68-1.51)  0.95 (0.63-1.42)  
n: absolute frequency of individuals (without weighting); %: prevalence of probable depressive disorder; 95%CI: 95% 
Confidence Interval; p: p value for age from Wald tests for models; OR: Odds Ratio; aOR: Odds Ratio adjusted for 
interview method, birthplace, degree of urbanization of the individuals’ residence area, Body Mass Index and social 
support (OSS). In the total sample aOR multivariable models were also adjusted by sex. 
All analyses were performed taking into account the weights derived from the complex sample design using the Taylor 
series linearization method. 
 
